303 related articles for article (PubMed ID: 15494991)
1. Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children.
Ventre K; Randolph A
Cochrane Database Syst Rev; 2004 Oct; (4):CD000181. PubMed ID: 15494991
[TBL] [Abstract][Full Text] [Related]
2. Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children.
Ventre K; Randolph AG
Cochrane Database Syst Rev; 2007 Jan; (1):CD000181. PubMed ID: 17253446
[TBL] [Abstract][Full Text] [Related]
3. WITHDRAWN: Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children.
Ventre K; Randolph A
Cochrane Database Syst Rev; 2010 May; 2010(5):CD000181. PubMed ID: 20464715
[TBL] [Abstract][Full Text] [Related]
4. Ribavirin for respiratory syncytial virus infection of the lower respiratory tract.
Randolph AG; Wang EE
Cochrane Database Syst Rev; 2000; (2):CD000181. PubMed ID: 10796503
[TBL] [Abstract][Full Text] [Related]
5. Ribavirin for respiratory syncytial virus lower respiratory tract infection. A systematic overview.
Randolph AG; Wang EE
Arch Pediatr Adolesc Med; 1996 Sep; 150(9):942-7. PubMed ID: 8790125
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection.
Sanders SL; Agwan S; Hassan M; van Driel ML; Del Mar CB
Cochrane Database Syst Rev; 2019 Aug; 8(8):CD009417. PubMed ID: 31446622
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children.
Andabaka T; Nickerson JW; Rojas-Reyes MX; Rueda JD; Bacic Vrca V; Barsic B
Cochrane Database Syst Rev; 2013 Apr; (4):CD006602. PubMed ID: 23633336
[TBL] [Abstract][Full Text] [Related]
8. Does ribavirin impact on the hospital course of children with respiratory syncytial virus (RSV) infection? An analysis using the pediatric investigators collaborative network on infections in Canada (PICNIC) RSV database.
Law BJ; Wang EE; MacDonald N; McDonald J; Dobson S; Boucher F; Langley J; Robinson J; Mitchell I; Stephens D
Pediatrics; 1997 Mar; 99(3):E7. PubMed ID: 9099772
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin treatment for respiratory syncytial virus infection.
Fuller H; Del Mar C
Cochrane Database Syst Rev; 2006 Oct; (4):CD004883. PubMed ID: 17054220
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of ribavirin in otherwise well infants with respiratory syncytial virus-associated respiratory failure. Pediatric Critical Study Group.
Moler FW; Steinhart CM; Ohmit SE; Stidham GL
J Pediatr; 1996 Mar; 128(3):422-8. PubMed ID: 8774517
[TBL] [Abstract][Full Text] [Related]
11. Long term follow-up of children hospitalized with respiratory syncytial virus lower respiratory tract infection and randomly treated with ribavirin or placebo.
Long CE; Voter KZ; Barker WH; Hall CB
Pediatr Infect Dis J; 1997 Nov; 16(11):1023-8. PubMed ID: 9384333
[TBL] [Abstract][Full Text] [Related]
12. Surfactant therapy for bronchiolitis in critically ill infants.
Ventre K; Haroon M; Davison C
Cochrane Database Syst Rev; 2006 Jul; (3):CD005150. PubMed ID: 16856080
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoids for acute viral bronchiolitis in infants and young children.
Patel H; Platt R; Lozano JM; Wang EE
Cochrane Database Syst Rev; 2004; (3):CD004878. PubMed ID: 15266547
[TBL] [Abstract][Full Text] [Related]
14. Respiratory syncytial virus disease: update on treatment and prevention.
Krilov LR
Expert Rev Anti Infect Ther; 2011 Jan; 9(1):27-32. PubMed ID: 21171875
[TBL] [Abstract][Full Text] [Related]
15. Ribavirin for Treatment of Subjects with Respiratory Syncytial Virus-Related Infection: A Systematic Review and Meta-Analysis.
Tejada S; Martinez-Reviejo R; Karakoc HN; Peña-López Y; Manuel O; Rello J
Adv Ther; 2022 Sep; 39(9):4037-4051. PubMed ID: 35876973
[TBL] [Abstract][Full Text] [Related]
16. Ribavirin for RSV lower respiratory tract infection.
Zamorski M
J Fam Pract; 1996 Dec; 43(6):536-7. PubMed ID: 8969696
[No Abstract] [Full Text] [Related]
17. WITHDRAWN: Immunoglobulin treatment for respiratory syncytial virus infection.
Fuller HL; Del Mar CB
Cochrane Database Syst Rev; 2010 Sep; 2010(9):CD004883. PubMed ID: 20824840
[TBL] [Abstract][Full Text] [Related]
18. Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis.
Robinson KA; Odelola OA; Saldanha I; McKoy N
Cochrane Database Syst Rev; 2010 Feb; (2):CD007743. PubMed ID: 20166098
[TBL] [Abstract][Full Text] [Related]
19. Nebulised ALX-0171 for respiratory syncytial virus lower respiratory tract infection in hospitalised children: a double-blind, randomised, placebo-controlled, phase 2b trial.
Cunningham S; Piedra PA; Martinon-Torres F; Szymanski H; Brackeva B; Dombrecht E; Detalle L; Fleurinck C;
Lancet Respir Med; 2021 Jan; 9(1):21-32. PubMed ID: 33002427
[TBL] [Abstract][Full Text] [Related]
20. Effect of an educational program on the treatment of RSV lower-respiratory-tract infection.
Purcell K; Fergie J
Am J Health Syst Pharm; 2003 Apr; 60(8):759-67. PubMed ID: 12749162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
